Form 4: Kiromic Biopharma CFO Brian Hungerford Acquires 1,000 Shares

Brian Hungerford, CFO of Kiromic Biopharma, recently purchased 1,000 shares of the company's common stock at a price of $3.18 per share.

Summary

• On June 12, 2024, Brian Hungerford, the CFO of Kiromic Biopharma, Inc., acquired 1,000 shares of common stock.
• The purchase price was $3.18 per share.
• Following the transaction, Hungerford directly owns 57,933 shares of Kiromic Biopharma.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of a stock purchase by an insider. While insider buying can be seen as positive, it's a small transaction and doesn't necessarily indicate a major shift in sentiment.

Positives

• The CFO's purchase of company stock could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders, like the CFO, trade their company's stock. These filings are closely watched by investors for signals about management's view of the company's prospects.

Stakeholder Impact

• The stock purchase could have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Kiromic Biopharma, Brian Hungerford, CFO, stock purchase, Form 4, KRBP, insider trading